Literature DB >> 25596269

Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.

Raffaella Origa1, Mario Cazzola2, Elisabetta Mereu1, Fabrice Danjou1, Susanna Barella3, Nicolina Giagu3, Renzo Galanello1, Dorine W Swinkels4.   

Abstract

Entities:  

Keywords:  erythropoiesis-hepcidin-iron store axis; hemoglobin H disease; β-thalassemia intermedia

Mesh：

Substances：

Year:  2015        PMID： 25596269      PMCID： PMC4420223          DOI： 10.3324/haematol.2014.115733

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Alpha thalassaemia is associated with increased soluble transferrin receptor levels.

Authors:  D C Rees; T N Williams; K Maitland; J B Clegg; D J Weatherall
Journal:  Br J Haematol       Date:  1998-11       Impact factor: 6.998

2.  Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders.

Authors:  Joyce J C Kroot; Coby M M Laarakkers; Anneke J Geurts-Moespot; Nicolaï Grebenchtchikov; Peter Pickkers; Annelies E van Ede; Hilde P E Peters; Edmée van Dongen-Lases; Jack F M Wetzels; Fred C G J Sweep; Harold Tjalsma; Dorine W Swinkels
Journal:  Clin Chem       Date:  2010-08-25       Impact factor: 8.327

3.  Hepcidin in iron overload disorders.

Authors:  George Papanikolaou; Michalis Tzilianos; John I Christakis; Dionisios Bogdanos; Konstantina Tsimirika; Julie MacFarlane; Y Paul Goldberg; Nikos Sakellaropoulos; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2005-01-25       Impact factor: 22.113

4.  Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.

Authors:  Sara Gardenghi; Maria F Marongiu; Pedro Ramos; Ella Guy; Laura Breda; Amy Chadburn; YiFang Liu; Ninette Amariglio; Gideon Rechavi; Eliezer A Rachmilewitz; William Breuer; Z Ioav Cabantchik; Diedra M Wrighting; Nancy C Andrews; Maria de Sousa; Patricia J Giardina; Robert W Grady; Stefano Rivella
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

5.  Serum hepcidin: reference ranges and biochemical correlates in the general population.

Authors:  Tessel E Galesloot; Sita H Vermeulen; Anneke J Geurts-Moespot; Siem M Klaver; Joyce J Kroot; Dorlene van Tienoven; Jack F M Wetzels; Lambertus A L M Kiemeney; Fred C Sweep; Martin den Heijer; Dorine W Swinkels
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

Review 6.  Hb H disease: clinical course and disease modifiers.

Authors:  Suthat Fucharoen; Vip Viprakasit
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

7.  Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Authors:  Raffaella Origa; Renzo Galanello; Tomas Ganz; Nicolina Giagu; Liliana Maccioni; Gavino Faa; Elizabeta Nemeth
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

8.  Erythroid marrow activity and hemoglobin H levels in hemoglobin H disease.

Authors:  I Papassotiriou; J Traeger-Synodinos; E Kanavakis; M Karagiorga; A Stamoulakatou; C Kattamis
Journal:  J Pediatr Hematol Oncol       Date:  1998 Nov-Dec       Impact factor: 1.289

9.  High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.

Authors:  Toshihiko Tanno; Natarajan V Bhanu; Patricia A Oneal; Sung-Ho Goh; Pamela Staker; Y Terry Lee; John W Moroney; Christopher H Reed; Naomi L C Luban; Rui-Hong Wang; Thomas E Eling; Richard Childs; Tomas Ganz; Susan F Leitman; Suthat Fucharoen; Jeffery L Miller
Journal:  Nat Med       Date:  2007-08-26       Impact factor: 53.440

10.  Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.

Authors:  Toshihiko Tanno; Prashanth Porayette; Orapan Sripichai; Seung-Jae Noh; Colleen Byrnes; Ajoy Bhupatiraju; Y Terry Lee; Julia B Goodnough; Omid Harandi; Tomas Ganz; Robert F Paulson; Jeffery L Miller
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113
View more
  12 in total

1.  Phosphatidylserine-exposed red blood cells and ineffective erythropoiesis biomarkers in patients with thalassemia.

Authors:  Siriyakorn Chansai; Supawadee Yamsri; Supan Fucharoen; Goonnapa Fucharoen; Nattiya Teawtrakul
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 2.  Hepcidin in the diagnosis of iron disorders.

Authors:  Domenico Girelli; Elizabeta Nemeth; Dorine W Swinkels
Journal:  Blood       Date:  2016-04-04       Impact factor: 22.113

Review 3.  β-Thalassemia.

Authors:  Raffaella Origa
Journal:  Genet Med       Date:  2016-11-03       Impact factor: 8.822

4.  Non-transfusion-dependent thalassemia: a complex mix of genetic entities yet to be fully discovered.

Authors:  Paolo Ricchi; Aldo Filosa; Aurelio Maggio; Suthat Fucharoen
Journal:  Biomed Res Int       Date:  2015-04-06       Impact factor: 3.411

Review 5.  Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes.

Authors:  Paolo Ricchi; Maria Marsella
Journal:  Drug Des Devel Ther       Date:  2015-12-16       Impact factor: 4.162

6.  EPO and hepcidin plasma concentrations in blood donors and β-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations.

Authors:  Nienke Schotten; Coby M M Laarakkers; Rian W Roelofs; Raffaella Origa; Marian G J van Kraaij; Dorine W Swinkels
Journal:  Am J Hematol       Date:  2017-03       Impact factor: 10.047

7.  Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory.

Authors:  Albertine E Donker; Charlotte C M Schaap; Vera M J Novotny; Roel Smeets; Tessa M A Peters; Bert L P van den Heuvel; Martine F Raphael; Anita W Rijneveld; Inge M Appel; Andre J Vlot; A Birgitta Versluijs; Michel van Gelder; Bernd Granzen; Mirian C H Janssen; Alexander J M Rennings; Frank L van de Veerdonk; Paul P T Brons; Dirk L Bakkeren; Marten R Nijziel; L Thom Vlasveld; Dorine W Swinkels
Journal:  Am J Hematol       Date:  2016-12       Impact factor: 10.047

8.  Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis.

Authors:  Yumei Huang; Rongrong Liu; Xiaoyun Wei; Jiaodi Liu; Lingyuan Pan; Gaohui Yang; Yongrong Lai
Journal:  Biomed Res Int       Date:  2019-01-30       Impact factor: 3.411

Review 9.  The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance.

Authors:  Simon Grootendorst; Jonathan de Wilde; Birgit van Dooijeweert; Annelies van Vuren; Wouter van Solinge; Roger Schutgens; Richard van Wijk; Marije Bartels
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

10.  Clinical interpretation of serum hepcidin-25 in inflammation and renal dysfunction.

Authors:  Michael X Chen; Nathan Kuehne; Andre Mattman; Jun Liu; Grace Van der Gugten; Bruce Wright
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2022-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.